HDAC1 and prostate carcinoma: miR-449a is down-regulated in prostate cancer and its expression negatively correlates with the expression of its direct target, the histone deacetylase 1 (HDAC1); introduction of miR-449a in prostate cancer cells affects cell growth and viability, in part by targeting HDAC1 [250].